The novel treatment of the medication represents a major breakthrough in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide690738.educationalimpactblog.com/63597910/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment